Ignite Creation Date:
2025-12-25 @ 4:41 AM
Ignite Modification Date:
2026-02-28 @ 11:15 AM
Study NCT ID:
NCT04176718
Status:
RECRUITING
Last Update Posted:
2025-10-07
First Post:
2019-11-22
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Sponsor:
Andrew Yee, MD
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
19-379
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None